Method for inhibiting myopia and application of prepared medicine

Method for inhibiting myopia and application of prepared medicine

  • CN 107,320,725 B
  • Filed: 06/29/2017
  • Issued: 10/09/2020
  • Est. Priority Date: 06/29/2017
  • Status: Active Grant
First Claim
Patent Images

1. The application of the scleral hypoxia inducible factor-1 alpha inhibitor in preparing the medicine for inhibiting the elongation of the ocular axis is characterized in that the scleral hypoxia inducible factor-1 alpha inhibitor is salidroside or formononetin.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×